Inhibitory immune checkpoints such as PD-1 binding to PD-L1 (on tumor cells and APCs) can recruit SHP2 and downregulate the phosphorylation of ZAP70 and PI3K in T cell intracellular signaling, thus driving T cells toward inactivation (Wu et al., 2021). Here, CD274 is linked to neoplasm.